QNCX
Quince Therapeutics·NASDAQ
--
--(--)
--
--(--)
8.07 / 10
Outperform
Analyst sentiment is mixed: 33% Strong Buy, 67% Neutral, with modest historical win rates. Fund‑flow sentiment is excellent (score 8.15) across all investor sizes. Despite strong liquidity, the stock has fallen 15.8%, reflecting cautious market expectations.
Fund Flow Rating
Analyst RatingStrong Buy
Wall Street Opinions
Strong Buy
Strong Buy
33%
Buy
0%
Hold
0%
Sell
0%
Strong Sell
0%
Date2026-01-30
InstitutionD. Boral Capital
Times predicted9
Historical Win Rate55.6%
What is the analyst consensus for QNCX?
- QNCX holds a Bullish analyst rating, with 33% of experts assigning a Strong Buy grade. Factoring in net Inflows from order flow data, the comprehensive Sentiment Score stands at 8.07/10 (Outperform).
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
